Amgen 2001 Annual Report Download - page 52

Download and view the complete annual report

Please find page 52 of the 2001 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 54

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54

AMGEN 2001 ANNUAL REPORT
50
George J. Morrow
Executive Vice President
Worldwide Sales and Marketing
Richard D. Nanula
Executive Vice President
Finance, Strategy and
Communications, and
Chief Financial Officer
Steven M. Odre
Senior Vice President
General Counsel and Secretary
Roger M. Perlmutter
Executive Vice President
Research and Development
Beth C. Seidenberg
Senior Vice President
Development
Kevin W. Sharer
Chairman of the Board
Chief Executive Officer,
and President
Board of Directors
David Baltimore
President
California Institute of Technology
Frank J. Biondi, Jr.
Senior Managing Director
WaterView Advisors LLC
William K. Bowes, Jr.
General Partner
U.S. Venture Partners
Jerry D. Choate
Retired Chairman and
Chief Executive Officer
The Allstate Corporation
Frederick W. Gluck
Retired Vice Chairman
Bechtel Group, Inc.
Franklin P. Johnson, Jr.
General Partner
Asset Management Partners
Board of Directors and Executive Officers
Stockholder Information
Corporate Office
One Amgen Center Drive
Thousand Oaks, California 91320-1799
(805) 447-1000
SEC Form 10-K
A copy of the company’s Annual Report on Form 10-K for the year ended
December 31, 2001, filed with the Securities and Exchange Commission, is
available without charge upon written request to Corporate Secretary, Amgen,
One Amgen Center Drive, Thousand Oaks, California 91320-1799; by calling
(800) 84-AMGEN; or by accessing the company’s Web site at www.amgen.com.
Transfer Agent and Registrar
American Stock Transfer & Trust Company
59 Maiden Lane
New York, New York 10038
Stockholder Inquiries
Inquiries related to stock transfers or lost certificates should be directed
to American Stock Transfer & Trust Company, (800) 937-5449 or
(212) 936-5100. General information regarding the company and recent
news releases can be obtained by contacting Amgen’s automated stockholder
information line at (800) 84-AMGEN or by accessing the company’s
Web site at www.amgen.com.
Independent Auditors
Ernst & Young LLP, Los Angeles, California
Annual Meeting
The Annual Meeting will be held on Thursday, May 16, 2002,
at 10:30 a.m. at the Beverly Hilton Hotel, 9876 Wilshire Boulevard,
Los Angeles, California 90210.
Price Range of Common Stock
The company’s common stock trades on The Nasdaq Stock Market under the
symbol AMGN. No cash dividends have been paid on the common stock to
date, and the company currently intends to retain any earnings for develop-
ment of the company’s business and repurchases of its common stock.
The following table sets forth, for the fiscal periods indicated, the range of
high and low closing sales prices of the common stock as quoted on The
Nasdaq Stock Market for the fiscal years 2001 and 2000:
Trademarks Listed in This Report
Amgen, Aranesp
™
, EPOGEN
®
,Kineret
™
, Neulasta
™
, NEUPOGEN
®
,
and STEMGEN
®
are trademarks of Amgen Inc. Immunex and ENBREL
®
are trademarks of Immunex Corporation.
Hotlines
Customer Service Hotline (800) 28-AMGEN
Investor Materials Hotline (800) 84-AMGEN
Job Hotline (800) 446-4007
Medical Information Connection (800) 77-AMGEN
Reimbursement Hotline (800) 272-9376
Safety Hotline (800) 835-2879
2001 2000
High Low High Low
4th Quarter $68.49 $56.03 $71.38 $54.13
3rd Quarter 65.66 54.01 78.00 64.94
2nd Quarter 70.02 51.51 70.38 51.31
1st Quarter 74.19 54.94 74.69 52.25
Steven Lazarus
Managing General Partner
ARCH Venture Partners, L.P.
Gilbert S. Omenn
Executive Vice President for Medical
Affairs, University of Michigan;
Chief Executive Officer, University
of Michigan Health System; and
Professor of Internal Medicine,
Human Genetics, and Public Health
Judith C. Pelham
President and Chief Executive Officer
Trinity Health
Adm. J. Paul Reason, USN (Ret.)
President and Chief Operating Officer
Metro Machine Corporation
Donald B. Rice
President and Chief Executive Officer
Agensys, Inc.
Kevin W. Sharer
Chairman of the Board
Chief Executive Officer,
and President
Amgen
Patricia C. Sueltz
Executive Vice President
Software Systems Group
Sun Microsystems, Inc.
Executive Officers
Fabrizio Bonanni
Senior Vice President
Quality and Compliance
Dennis M. Fenton
Executive Vice President
Brian McNamee
Senior Vice President
Human Resources